The 4-Second Blind Spot

Mike Cymbor, OD, FAAO, discusses an enduring gap in glaucoma care that could be addressed with smart contact lenses.

Category	Detail
Condition	Glaucoma
Key Mechanisms	Continuous intraocular pressure monitoring and theranostic treatment.
Target Population	Patients with glaucoma.
Care Setting	Optometric and ophthalmologic practices.

Current IOP measurement methods capture only a fraction of pressure fluctuations.
24-hour IOP monitoring reveals clinically significant pressure variations.
Emerging technologies include smart contact lenses for continuous monitoring and treatment.
Challenges include maintaining accuracy, safety, and regulatory approval.
Theranostic lenses may automatically release medication in response to elevated IOP.

Consider investigational smart lenses for continuous IOP monitoring and treatment.

Regularly assess IOP, but recognize limitations of traditional measurement methods.

Individuals diagnosed with glaucoma requiring IOP management.

Innovative contact lenses may provide real-time monitoring and responsive treatment.

Clinical Scorecard: The 4-Second Blind Spot